Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

Yme1l1 Knockout HL-1 Cell Line

The Yme1l1 Knockout HL-1 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from mouse atrial cardiomyocyte HL-1 cells, engineered with a targeted disruption of…
Cat. No. ARG44224

Yipf5 Knockout INS-1 Cell Line

The Yipf5 Knockout INS-1 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the rat insulinoma INS-1 background, targeting the Yipf5 gene. This model…
Cat. No. ARG44223

YAP1 Knockout BEAS-2B Cell Line

The YAP1 Knockout BEAS-2B Cell Line provides a CRISPR/Cas9-based gene-disrupted model of the Hippo effector YAP1 in immortalized normal human bronchial epithelial cells. This knockout…
Cat. No. ARG44222

XBP1 Knockout EO771 Cell Line

The XBP1 Knockout EO771 Cell Line is a CRISPR/Cas9-edited knockout cell line of the murine EO771 triple-negative breast cancer model, in which the gene encoding…
Cat. No. ARG44221

Xbp1 Knockout AC16 Cell Line

The Xbp1 Knockout AC16 Cell Line is a CRISPR/Cas9-edited human ventricular cardiomyocyte line with targeted disruption of the XBP1 transcription factor, a central regulator of…
Cat. No. ARG44220

WDR33 Knockout HEK293T Cell Line

The WDR33 Knockout HEK293T Cell Line is a CRISPR/Cas9-edited knockout model derived from the human embryonic kidney HEK293T line. By disrupting the WDR33 gene, it…
Cat. No. ARG44219

WASL Knockout HaCaT Cell Line

The WASL Knockout HaCaT Cell Line is a CRISPR/Cas9-edited human keratinocyte line with targeted disruption of the WASL gene, encoding the actin nucleation-promoting factor N-WASP.…
Cat. No. ARG44218

WASF2 Knockout U2OS Cell Line

The WASF2 Knockout U2OS Cell Line is a CRISPR/Cas9-edited knockout of the WAVE2 gene in human U2OS osteosarcoma cells. WASF2 acts downstream of Rac1 to…
Cat. No. ARG44217

Vsir Knockout BV-2 Cell Line

The Vsir Knockout BV-2 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the mouse BV-2 microglial cell line, offering a powerful model for…
Cat. No. ARG44216

VSIR Knockout Jurkat E6.1 Cell Line

CRISPR/Cas9-edited knockout cell line targeting the VSIR gene (VISTA) in the Jurkat E6.1 human T lymphoblast background. This loss-of-function model abrogates expression of the V-domain…
Cat. No. ARG44215

Vsig4 Knockout MH-S Cell Line

The Vsig4 Knockout MH-S Cell Line is a CRISPR/Cas9-edited murine alveolar macrophage cell line (MH-S) lacking functional Vsig4, a receptor for complement fragments C3b and…
Cat. No. ARG44214

VNN1 Knockout THP-1 Cell Line

CRISPR/Cas9-mediated knockout of VNN1 in the human THP-1 monocytic cell line eliminates pantetheinase activity, blocking the conversion of pantetheine to cysteamine and pantothenic acid. Loss…
Cat. No. ARG44213

Loading products...